The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.

UNLABELLED: As SPECT/CT technology evolves, its applications and indications need to be evaluated clinically for more efficient and cost-effective use. This retrospective study evaluated the clinical value of simultaneously acquired (99m)Tc-sestamibi SPECT/CT versus conventional SPECT in diagnosing and locating parathyroid adenomas or hyperplasia in patients with primary hyperparathyroidism. METHODS: Immediately and 60 minutes after intravenous administration of 740-925 MBq of (99m)Tc-sestamibi, static planar images of the neck and chest were obtained. SPECT/CT images were acquired 30 minutes after injection. Two experienced masked readers independently evaluated whether conventional SPECT images provided information beyond what was available from the planar images either by changing the diagnosis or by better locating the glands and whether the SPECT/CT images provided information beyond what was available from the planar plus conventional SPECT images. Forty-eight consecutive patients with a clinical diagnosis of primary hyperparathyroidism were included in the study. The 32 whose scans showed positive results underwent surgical resection and were examined histopathologically. RESULTS: Planar and SPECT imaging, with or without CT fusion, identified 89% of the surgically confirmed diseased parathyroid glands. Use of SPECT/CT changed the diagnosis in only 1 patient (2%) from positive to negative and better located the glands in only 4 patients (8%). SPECT/CT was particularly helpful in locating the 2 ectopic parathyroid adenomas diagnosed in this cohort. Tracer retention in diseased glands did not correlate with histologic characteristics. Also, biochemical markers did not correlate with the scan findings. CONCLUSION: SPECT/CT has no significant clinical value additional to that of conventional SPECT for parathyroid imaging except in locating ectopic parathyroid glands. Eliminating the CT acquisition will spare patients the additional time, radiation exposure, and expense.

Strategies for formulating appropriate MDCT techniques when imaging the chest, abdomen, and pelvis in pediatric patients.

OBJECTIVE: Our aim was to formulate appropriate MDCT chest and abdominopelvic CT scan protocols for pediatric patients. MATERIALS AND METHODS: Surface radiation dose measurements from a set of anthropomorphic phantoms (nominal 1 year old, 5 year old, and 10 year old) and an adult phantom were compared with standard CT dose index measurements. Image-noise values on axial 5-mm-thick anthropomorphic phantom images were obtained as a measure of image quality. RESULTS: Peripheral CT dose index values obtained with the standard 16-cm acrylic phantom were within approximately 10% of the CT surface dose measurements for the pediatric anthropomorphic phantoms for both chest and abdominopelvic scan protocols. The noise value for the adult phantom image acquired using a typical clinical CT technique was identified, and targeting this level of noise for pediatric CT examinations resulted in a decrease in dose of 60-90%. Initially, 80 kVp was selected for use with very small children; however, beam-hardening artifacts were severe enough to cause us to abandon this option. Current pediatric protocols at M. D. Anderson Cancer Center rely on 100- and 120-kVp settings. The display field-of-view parameter can be used as a surrogate for patient size to develop clinical pediatric CT protocol charts. CONCLUSION: CT dose index measurements obtained using the 16-cm standard acrylic phantom are sufficiently accurate for estimating chest and abdominopelvic CT entrance exposures for pediatric patients of the same approximate size as the anthropomorphic phantoms used in this study. Image-noise measurements can be used to adjust chest and abdominopelvic CT techniques for pediatric populations, resulting in a decrease in measured entrance dose by 60-90%.